Surgery of low-grade gliomas: towards a ‘functional neurooncology’
Author:
- 1 November 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 21 (6) , 543-549
Abstract
For a long time, surgery of diffuse low-grade glioma was debated because of the poor knowledge of the natural history, the lack of objective evaluation of the extent of resection, a too short follow-up and the functional risk. Recently, new technical and conceptual advances in surgery have dramatically changed the management. Despite the lack of class I evidence, there is currently growing evidence that a more extensive surgical resection of low-grade glioma is associated with a more favorable life expectancy. The use of cortical and subcortical functional mapping allows us to tailor the resection according to individual functional boundaries, thus optimizing the extent of resection while minimizing the risk of permanent deficit less than 2%. The quality of life may also be improved, thanks to seizures control and functional rehabilitation. Early surgery is currently the first treatment in low-grade glioma. Re-operation can also be considered, possibly more extensive than the first one, thanks to a functional remapping and/or a tumor shrink induced by neoadjuvant treatment, especially chemotherapy. The next step is to better evaluate the quality of life and to continue to improve it in addition to the survival to evolve towards a 'functional neurooncology'.Keywords
This publication has 50 references indexed in Scilit:
- Current concepts in the evaluation and management of WHO grade II gliomasJournal of Neuro-Oncology, 2009
- Prognostic significance of imaging contrast enhancement for WHO grade II gliomasNeuro-Oncology, 2009
- Low-Grade Gliomas: Do Changes in rCBV Measurements at Longitudinal Perfusion-weighted MR Imaging Predict Malignant Transformation?Radiology, 2008
- Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigmNeurosurgical Review, 2008
- Proton magnetic resonance spectroscopy predicts proliferative activity in diffuse low-grade gliomasJournal of Neuro-Oncology, 2007
- Longitudinal cognitive follow-up in low grade gliomasJournal of Neuro-Oncology, 2007
- Dynamic history of low‐grade gliomas before and after temozolomide treatmentAnnals of Neurology, 2007
- Prognostic value of initial magnetic resonance imaging growth rates for World Health Organization grade II gliomasAnnals of Neurology, 2006
- Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trialThe Lancet, 2005
- Survival rates in patients with low‐grade glioma after intraoperative magnetic resonance image guidanceCancer, 2005